Injection Monitoring
Injection Monitoring - Related Videos
06:11
Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection
0 Views •
Cited by 2 •
2024
Here, we present a protocol to establish an intracytoplasmic sperm injection (ICSI)-embryo transfer (ET) mouse model, allowing us to observe age-related changes in glucose metabolism that may be attributed to ICSI, providing insights into its potential long-term impacts on human development.
03:45
Intraductal Injection: Delivering Injection Mix into the Ducts of the Mouse Mammary Gland
0 Views •
2023
This video describes an intraductal injection technique where we deliver injection mix into the ducts of mouse mammary glands.
01:36
Anesthesia and Monitoring in a Rabbit Model
0 Views •
2026
All animal procedures described here must be conducted in accordance with institutional animal ethics guidelines and approved by IACUC. All procedures must follow the principles of the 3Rs—Replacement, Reduction, and Refinement—and must be performed by trained personnel. Anesthesia is an essential component of rabbit surgical and experimental procedures because it prevents pain, reduces stress responses, and helps immobilize the animal during handling and manipulation when general anesthesia is...
10:28
An Injectable and Drug-loaded Supramolecular Hydrogel for Local Catheter Injection into the Pig Heart
0 Views •
Cited by 21 •
2015
Supramolecular hydrogelators based on ureido-pyrimidinones allow full control over the macroscopic gel properties and the sol–gel switching behavior using pH. Here, we present a protocol for formulating and injecting such a supramolecular hydrogelator via a catheter delivery system for local delivery directly in relevant areas in the pig heart.
01:31
Anesthesia and Monitoring in a Pig Model
0 Views •
2026
All animal procedures described here must be conducted in accordance with institutional animal ethics guidelines and approved by IACUC. All procedures must follow the principles of the 3Rs—Replacement, Reduction, and Refinement—and must be performed by trained personnel. Pigs are commonly used in biomedical and surgical research because of their anatomical and physiological similarities to humans. During procedures, anesthesia prevents pain, reduces stress, limits movement, and supports animal...
FAQs
Volume, flow rate, timing, and target site provide the main checkpoints for evaluating an injection. Together, they describe how much substance entered the system, how quickly delivery occurred, when it happened, and where it was intended to act. Recording these variables helps connect delivery conditions with later biological responses and improves interpretation across experiments.
Confirming the target site helps determine whether a reagent, drug, nucleic acid, or cellular suspension reached the tissue selected for the study. If delivery occurs elsewhere, a visible or measured response may not reflect the intended treatment. Monitoring location therefore helps distinguish treatment effects from consequences of inaccurate placement or unintended exposure.
Delivery measurements alone show what was administered, whereas biological observations indicate how the system responded. Considering both allows researchers to relate volume, flow rate, timing, and site to measured or visible effects. This paired record supports more reliable conclusions because an unexpected outcome can be examined alongside the conditions under which injection occurred.
A basic workflow records the planned injection conditions, observes the delivery as it occurs, and documents the target site and timing. Researchers then relate those records to visible or measured biological responses, including any unintended effects. Comparing this information across samples or experimental groups helps identify inconsistent delivery and supports more dependable interpretation.
Consistency makes injection conditions easier to compare between experiments, samples, or treatment groups. Recording the same key variables, including volume, flow rate, timing, and target site, reduces uncertainty about whether different outcomes arose from the biological treatment or from delivery differences. This strengthens reproducibility and makes experimental results easier to interpret.
The approach is particularly relevant when studies depend on delivering a drug, reagent, nucleic acid, or cellular suspension to a specified tissue. It supports drug-delivery research, gene-transfer studies, and development of experimental models. In each setting, monitoring helps verify intended delivery, identify unintended effects, and connect treatment conditions with biological outcomes.